195 related articles for article (PubMed ID: 29384023)
1. Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Lalonde L
J Manag Care Spec Pharm; 2018 Feb; 24(2):173-181. PubMed ID: 29384023
[TBL] [Abstract][Full Text] [Related]
2. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a training and communication-network nephrology program for community pharmacists.
Lalonde L; Normandeau M; Lamarre D; Lord A; Berbiche D; Corneille L; Prud'homme L; Laliberté MC
Pharm World Sci; 2008 Dec; 30(6):924-33. PubMed ID: 18802782
[TBL] [Abstract][Full Text] [Related]
4. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
5. [Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study in Dutch community pharmacies].
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Ned Tijdschr Geneeskd; 2016; 160():D439. PubMed ID: 27924735
[TBL] [Abstract][Full Text] [Related]
6. Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory-based qualitative study.
Quintana-Bárcena P; Lalonde L; Lauzier S
Res Social Adm Pharm; 2019 Feb; 15(2):145-153. PubMed ID: 29709530
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of criteria for classifying severity of drug-related problems in chronic kidney disease: A community pharmacy perspective.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Jouini G; Lalonde L
Am J Health Syst Pharm; 2015 Nov; 72(21):1876-84. PubMed ID: 26490822
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Desrochers JF; Lemieux JP; Morin-Bélanger C; Paradis FS; Lord A; Bell R; Berbiche D; Bárcena PQ; Séguin NC; Desforges K; Legris MÈ; Sauvé P; Lalonde L
Am J Kidney Dis; 2011 Oct; 58(4):527-35. PubMed ID: 21778005
[TBL] [Abstract][Full Text] [Related]
9. Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program.
Krähenbühl JM; Decollogny A; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):816-22. PubMed ID: 18551382
[TBL] [Abstract][Full Text] [Related]
10. Completeness of medication reviews provided by community pharmacists.
Kwint HF; Faber A; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2014 Jun; 39(3):248-52. PubMed ID: 24521180
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions.
Zhang S; Zhang GB; Huang P; Ren Y; Lin B; Shao YF; Ye XL
BMC Geriatr; 2023 Dec; 23(1):849. PubMed ID: 38093184
[TBL] [Abstract][Full Text] [Related]
13. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.
Belaiche S; Romanet T; Allenet B; Calop J; Zaoui P
J Nephrol; 2012; 25(5):782-8. PubMed ID: 22322820
[TBL] [Abstract][Full Text] [Related]
14. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system.
Verdoorn S; Kwint HF; Hoogland P; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2018 Apr; 43(2):224-231. PubMed ID: 28971492
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug-related problems in older polypharmacy primary care patients.
Kovačević SV; Miljković B; Ćulafić M; Kovačević M; Golubović B; Jovanović M; Vučićević K; de Gier JJ
J Eval Clin Pract; 2017 Aug; 23(4):860-865. PubMed ID: 28370742
[TBL] [Abstract][Full Text] [Related]
16. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial.
Vinks TH; Egberts TC; de Lange TM; de Koning FH
Drugs Aging; 2009; 26(2):123-33. PubMed ID: 19220069
[TBL] [Abstract][Full Text] [Related]
18. Drug-related problems identified during geriatric medication review in the community pharmacy.
Rhalimi M; Rauss A; Housieaux E
Int J Clin Pharm; 2018 Feb; 40(1):109-118. PubMed ID: 29188412
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical care research and education project: pharmacists' interventions.
Kassam R; Farris KB; Burback L; Volume CI; Cox CE; Cave A
J Am Pharm Assoc (Wash); 2001; 41(3):401-10. PubMed ID: 11372905
[TBL] [Abstract][Full Text] [Related]
20. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
